BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7647943)

  • 21. A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion.
    Creinin MD; Carbonell JL; Schwartz JL; Varela L; Tanda R
    Contraception; 1999 Jan; 59(1):11-6. PubMed ID: 10342081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate and misoprostol for early abortion: a multicenter trial. Acceptability.
    Creinin MD; Burke AE
    Contraception; 1996 Jul; 54(1):19-22. PubMed ID: 8804803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
    Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L
    JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early medical termination pregnancy with methotrexate and misoprostol in lower segment cesarean section cases.
    Gautam R; Agrawal V
    J Obstet Gynaecol Res; 2003 Aug; 29(4):251-6. PubMed ID: 12959148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study.
    Pocius KD; Bartz D; Maurer R; Stenquist A; Fortin J; Goldberg AB
    Contraception; 2017 Mar; 95(3):263-268. PubMed ID: 27621046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical abortion with oral methotrexate and vaginal misoprostol.
    Creinin MD; Vittinghoff E; Schaff E; Klaisle C; Darney PD; Dean C
    Obstet Gynecol; 1997 Oct; 90(4 Pt 1):611-6. PubMed ID: 9380325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misoprostol 3, 4, or 5 days after methotrexate for early abortion. A randomized trial.
    Carbonell I Esteve JL; Velazco A; Varela L; Cabezas E; Fernández C; Sánchez C
    Contraception; 1997 Sep; 56(3):169-74. PubMed ID: 9347208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate and misoprostol for early abortion in adolescent women.
    Creinin MD; Wiebe E; Gold M
    J Pediatr Adolesc Gynecol; 1999 May; 12(2):71-7. PubMed ID: 10326191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate and misoprostol for early abortion.
    Creinin MD; Darney PD
    Contraception; 1993 Oct; 48(4):339-48. PubMed ID: 8222661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion.
    Schaff EA; Stadalius LS; Eisinger SH; Franks P
    J Fam Pract; 1997 Apr; 44(4):353-60. PubMed ID: 9108832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
    Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
    Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.
    el-Refaey H; Templeton A
    Br J Obstet Gynaecol; 1994 Sep; 101(9):792-6. PubMed ID: 7947529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Medical abortion using methotrexate and misoprostol. Efficacy and tolerability].
    Iamakov K; Pekhlivanov B; Amaliev I
    Akush Ginekol (Sofiia); 2005; 44(3):16-8. PubMed ID: 16028385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaginal misoprostol for early second-trimester abortion.
    Carbonell JL; Valera L; Velazco A; Tanda R; Sánchez C
    Eur J Contracept Reprod Health Care; 1998 Jun; 3(2):93-8. PubMed ID: 9710713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaginal misoprostol for abortion at 10-13 weeks' gestation.
    Carbonell JL; Varela L; Velazco A; Tanda R; Sánchez C
    Eur J Contracept Reprod Health Care; 1999 Mar; 4(1):35-40. PubMed ID: 10367194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion.
    Creinin MD; Potter C; Holovanisin M; Janczukiewicz L; Pymar HC; Schwartz JL; Meyn L
    Am J Obstet Gynecol; 2003 Mar; 188(3):664-9. PubMed ID: 12634638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of remote and in-clinic follow-up after methotrexate/misoprostol abortion.
    Dunn S; Panjwani D; Gupta M; Meaney C; Morgan R; Feuerstein E
    Contraception; 2015 Sep; 92(3):220-6. PubMed ID: 26068140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate pharmacokinetics and effects in women receiving methotrexate 50 mg and 60 mg per square meter for early abortion.
    Creinin MD; Krohn MA
    Am J Obstet Gynecol; 1997 Dec; 177(6):1444-9. PubMed ID: 9423749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abortion induced with methotrexate and misoprostol.
    Wiebe ER
    CMAJ; 1996 Jan; 154(2):165-70. PubMed ID: 8548705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.